Skip to main content

Table 1 m6A and autophagy associated factors involved in m6A-autophagy interaction and their potential mechanisms in human diseases

From: Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases

Human

Diseases

m6A-associated factors

Autophagy-associated factors

Up/Down regulation of m6A methylation

Association between m6A modification and autophagy

Potential Mechanisms

References

Adipogenesis and Obesity

FTO

ATG5/ATG7

Up

Negative

YTHDF2-dependent ATG5/ATG7

mRNA degradation

[18]

Azoospermatism and oligo-spermatism

METTL14

/ALKBH5

AMPK regulator

(PPM1A/

CAMKK2)

Up

Negative

m6A modification reduced AMPK activity

[48]

Ischemic heart disease

METTL3/ ALKBH5

TFEB

Up

Negative

HNRNPD-dependent TFEB decreased expression

[17]

IVD degeneration

ALKBH5

FIP200

Up

Negative

YTHDF2-mediated FIP200 mRNA degradation

[91]

HCC

YTHDF1

ATG2A/ATG14

/

/

HIF-1α-induced YTHDF1 expression promotes ATG2A/ATG14 translation

[94]

NSCLC

ALKBH5

UBE2C/ATG3/LC3

Down

Negative

ALKBH5 activated increases UBE2C-autophagy axis

[95]

CRC

IGF2BP2

Ubiquitin-autophagy pathway

/

/

IGF2BP2 increases MYC mRNA stability

[96]

Melanoma

FTO

Metabolic starvation stress

Down

Induced

YTHDF2-mediated promotes melanoma tumorigenesis and anti-PD-1 resistance

[98]

Drug resistance in NSCLC

METTL3

ATG5/ATG7

Up

Positive

METTL3 positively regulated autophagy in gefitinib resistance

[19]

Drug resistance in HCC

METTL3

ATG5/ATG7/

ATG16L1

Down

Negative

METTL3-mediated FOXO3 mRNA stabilization and negative impact on ATG proteins in sorafenib resistance

[51]

Drug resistance in CGC

METTL3

SQSTM1

Up

Negative

Impaired autophagic degradation of lncRNA stabilizes ARHGAP5 mRNA via facilitating METTL3 in chemoresistance

[99]

  1. IVD Intervertebral disc, HCC hepatocellular carcinoma, NSCLC non-small cell lung cancer, CRC colorectal cancer, CGC chemoresistant gastric cancer